Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız: http://hdl.handle.net/11452/25460
Başlık: Sale strategies of pharmaceutical companies in a "pharmerging" country: The problems will not improve if the gaps remain
Yazarlar: Uludağ Üniversitesi/Tıp Fakültesi/Tıp Etiği Anabilim Dalı.
0000-0001-5376-3499
Civaner, Murat
S-4188-2019
24075622600
Anahtar kelimeler: Health care sciences & services
Marketing
Drug industry
Physicians
Medical ethics
Professionalism
Drug companies
Medical journals
Industry
Doctors
Physicians
Sponsorship
Association
Guidelines
Education
Authors
Yayın Tarihi: Ağu-2012
Yayıncı: Elsevier Ireland
Atıf: Civaner, M. (2012). "Sale strategies of pharmaceutical companies in a "pharmerging" country: The problems will not improve if the gaps remain". Health Policy, 106(3), 225-232.
Özet: Objective: This study aimed to examine the types of sales strategies used by pharmaceutical companies in a "pharmerging" market and to gain insight into the ways of avoiding the negative effects of these strategies. Method: In-depth interviews were conducted with 22 physicians and company employees in the six largest cities of Turkey. The interviews were analyzed using content analysis. Results: Various sales strategies, both legal and illegal, are universally applied. These methods target prescribers, patients, pharmacists, and society in general. Different types of companies, organizations, professionals, and science and ethical principles are used as means. Companies intervene immediately to prevent developments that may decrease sales, and exploit the educational and infrastructural needs. In contrast, physicians are overconfident about the effects of marketing and insufficiently educated on how to cope with the strategies and the drugs on the market, which make them vulnerable. Under these conditions, along with worldwide competition and economic volatility, policies that aim to set frameworks for pharmaceutical relationships have failed. Conclusion: Interventions are crucial, including instituting a national drug policy, minimizing the exposure to marketing, and addressing the educational and infrastructural needs of the prescribers. Without these interventions, gaps will continue to be exploited by companies for their own advantage, and the problems related to marketing will persist.
Açıklama: Bu çalışma, Ankara Üniversitesi Sağlık Bilimleri Enstitüsünde Berna Arda'nın danışmanlığında Murat Civaner tarafından yazılan "Türkiye'de ilaç şirketlerinin kullandıkları pazarlama yöntemleri ve hekimlerin bu konudaki değerlendirmelerinin etik açıdan sorgulanması" adlı doktora tezine dayanılarak hazırlanmıştır.
URI: https://doi.org/10.1016/j.healthpol.2012.05.006
https://www.sciencedirect.com/science/article/pii/S0168851012001509
http://hdl.handle.net/11452/25460
ISSN: 0168-8510
1872-6054
Koleksiyonlarda Görünür:PubMed
Scopus
Web of Science

Bu öğenin dosyaları:
Bu öğeyle ilişkili dosya bulunmamaktadır.


DSpace'deki bütün öğeler, aksi belirtilmedikçe, tüm hakları saklı tutulmak şartıyla telif hakkı ile korunmaktadır.